Case for continuing community NIV and CPAP during the COVID-19 epidemic

Baker, Jillian G.; Sovani, Milind

doi:10.1136/thoraxjnl-2020-214913

Cited by 49 publications

(40 citation statements)

References 2 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…When using a patient's own device and pressure setting adapted to the emergency situation, patients with previous CPAP or NIV require an appropriate mask and tube change, including the insertion of a virus filter [125].…”

Section: Practical Tips From a Hygiene Perspectivementioning

confidence: 99%

Position Paper for the State-of-the-Art Application of Respiratory Support in Patients with COVID-19

et al. 2020

View full text Add to dashboard Cite

Against the background of the pandemic caused by infection with the SARS-CoV-2 virus, the German Respiratory Society has appointed experts to develop therapy strategies for CO-VID-19 patients with acute respiratory failure (ARF). Here we present key position statements including observations about the pathophysiology of (ARF). In terms of the pathophysiology of pulmonary infection with SARS-CoV-2, COV-ID-19 can be divided into 3 phases. Pulmonary damage in advanced COVID-19 often differs from the known changes in acute respiratory distress syndrome (ARDS). Two types (type L and type H) are differentiated, corresponding to early-and late-stage lung damage. This differentiation should be taken into consideration in the respiratory support of ARF. The assessment of the extent of ARF should be based on arterial or This is the translation of a German article "Positionspapier zur praktischen Umsetzung der apparativen Differenzialtherapie der akuten respiratorischen Insuffizienz bei COVID-19" by Pfeifer et al. [Pneumologie. Stuttgart: Thieme; 2020]. Translated by: Dipl. Dol. G. M. Mundt.

show abstract

Section: Practical Tips From a Hygiene Perspectivementioning

confidence: 99%

Position Paper for the State-of-the-Art Application of Respiratory Support in Patients with COVID-19

et al. 2020

View full text Add to dashboard Cite

show abstract

“…As OSA may cause various degrees of reduced arterial oxygen saturation and additional cardio-metabolic complications, routine CPAP home use is often indicated in women with PCOS and OSA [19,25,80,81]. However, because CPAP is regarded as a high-risk aerosol-generating procedure which may increase the risk of SARS-CoV-2 transmission to other household members, routine CPAP therapy at home has been the subject of recent debate [82][83][84]. Particularly for any OSA patient with suspected or confirmed COVID-19 who is self-isolating at home, it is reasonable to consider discontinuing CPAP therapy for a short period due to the potential risk of SARS-CoV-2 aerosolized transmission from the CPAP use to other household members [82,85].…”

Section: Antihypertensive Medicationsmentioning

confidence: 99%

Polycystic ovary syndrome (PCOS) and COVID-19: an overlooked female patient population at potentially higher risk during the COVID-19 pandemic

Kyrou

Karteris

Robbins

et al. 2020

BMC Med

100

View full text Add to dashboard Cite

Background: In women of reproductive age, polycystic ovary syndrome (PCOS) constitutes the most frequent endocrine disorder. Women with PCOS are considered to typically belong to an age and sex group which is at lower risk for severe COVID-19. Main body: Emerging data link the risk of severe COVID-19 with certain factors such as hyper-inflammation, ethnicity predisposition, low vitamin D levels, and hyperandrogenism, all of which have known direct associations with PCOS. Moreover, in this common female patient population, there is markedly high prevalence of multiple cardio-metabolic conditions, such as type 2 diabetes, obesity, and hypertension, which may significantly increase the risk for adverse COVID-19-related outcomes. This strong overlap of risk factors for both worse PCOS cardiometabolic manifestations and severe COVID-19 should be highlighted for the clinical practice, particularly since women with PCOS often receive fragmented care from multiple healthcare services. Comprehensively informing women with PCOS regarding the potential risks from COVID-19 and how this may affect their management is also essential. Conclusion: Despite the immense challenges posed by the COVID-19 outbreak to the healthcare systems in affected countries, attention should be directed to maintain a high standard of care for complex patients such as many women with PCOS and provide relevant practical recommendations for optimal management in the setting of this fast moving pandemic.

show abstract

“…A focus on the OSA population during the outbreak is of particular interest for two main reasons: (i) OSA is a multi-morbid disease with up to 70% of patients being obese [3] and exhibiting a high prevalence of cardio-metabolic comorbidities. Such a clinical context is expected to be associated with a higher risk of severe forms of COVID-19 and a higher mortality rate [4]; (ii) CPAP treatment is considered as a high-risk aerosol-generating procedure potentially facilitating viral dispersion into the environment and transmission of infection [5][6][7]. As a result, CPAP-treated patients have often received contradictory information regarding their individual level of risk during the pandemic and ambiguous instructions as whether to continue or stop CPAP.…”

Section: Take-home Messagementioning

confidence: 99%

Continuous positive airway pressure-treated patients' behaviours during the COVID-19 crisis

et al. 2020

View full text Add to dashboard Cite

Case for continuing community NIV and CPAP during the COVID-19 epidemic

Cited by 49 publications

References 2 publications

Position Paper for the State-of-the-Art Application of Respiratory Support in Patients with COVID-19

Position Paper for the State-of-the-Art Application of Respiratory Support in Patients with COVID-19

Polycystic ovary syndrome (PCOS) and COVID-19: an overlooked female patient population at potentially higher risk during the COVID-19 pandemic

Continuous positive airway pressure-treated patients' behaviours during the COVID-19 crisis

Contact Info

Product

Resources

About